Both Alzheimer’s disease (AD) and aging have aging-related cognitive dysfunction with a high incidence. These neurological diseases cause serious cognitive problems in patients’ daily life. But the cognitive dysfunction mechanism in-depth of aging is far less known than that of AD.
Objective:
To reveal the different mechanisms of AD and aging-related cognitive dysfunction, we compared the mechanisms of aging and AD through analysis of differentially expressed genes.
Methods:
Mice were divided into four groups (3-month C57BL, 16-month C57BL, 3-month 3xTg AD mice, and 16-month 3xTg AD mice) according to genotype and age. The Morris water maze was employed to investigate the spatial cognition of mice. Differential expressions of genes of AD and aging were analyzed through RNA sequencing and GO, KEGG, Reactome analysis, and the dynamic change trend analysis. Microglia was stained with immunofluorescence and its numbers were counted for analysis.
Results:
The cognitive function of elderly mice were worse through testing with the Morris water maze. The cognitive function of 16-month 3xTg AD mice were worse than 16-month C57BL mice. The alteration tendencies of DE genes were uncovered, and microglia numbers increased during aging and AD progression through immunofluorescence.
Conclusion:
These results suggest that immune-related pathways might play a critical role in aging and AD-related cognitive dysfunction. Our research will help to provide some new potential targets for treating cognitive dysfunction in aging and AD.
AmanollahiM, AmanollahiS, AnjomshoaA, DolatshahiM (2021) Mitigating the negative impacts of aging on cognitive function; modifiable factors associated with increasing cognitive reserve. Eur J Neurosci53, 3109–3124.
4.
GreenwoodPM (2007) Functional plasticity in cognitive aging: Review and hypothesis. Neuropsychology21, 657–673.
5.
SonntagWE, RamseyM, CarterCS (2005) Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging. Ageing Res Rev4, 195–212.
6.
StranahanAM, MattsonMP (2012) Metabolic reserve as a determinant of cognitive aging. J Alzheimers Dis30(Suppl 2), S5–13.
7.
ZhangH, DaviesKJA, FormanHJ (2015) Oxidative stress response and Nrf2 signaling in aging. Free Radic Biol Med88, 314–336.
8.
Couillard-DesprésS (2013) Hippocampal neurogenesis and ageing. Curr Top Behav Neurosci15, 343–355.
9.
ShirzadiZ, RabinJ, LaunerLJ, BryanRN, Al-OzairiA, ChhatwalJ, Al-OzairiE, DetreJA, BlackSE, SwardfagerW, MacIntoshBJ (2023) Metabolic and vascular risk factor variability over 25 years relates to midlife brain volume and cognition. J Alzheimers Dis91, 627–635.
10.
ChatterjeeS, SealeyM, RuizE, PegasiouCM, BrookesK, GreenS, CrisfordA, Duque-VasquezM, LuckettE, RobertsonR, RichardsonP, VajramaniG, GrundyP, BultersD, ProudC, Vargas-CaballeroM, MudherA (2023) Age-related changes in tau and autophagy in human brain in the absence of neurodegeneration. PLoS One18, e0262792.
11.
TownsendRF, LoganD, O’NeillRF, PrinelliF, WoodsideJV, McEvoyCT (2023) Whole dietary patterns, cognitive decline and cognitive disorders: A systematic review of prospective and intervention studies. Nutrients15, 333.
12.
YinF, SanchetiH, PatilI, CadenasE (2016) Energy metabolism and inflammation in brain aging and Alzheimer’s disease. Free Radic Biol Med100, 108–122.
13.
PengW, MinakakiG, NguyenM, KraincD (2019) Preserving lysosomal function in the aging brain: Insights from neurodegeneration. Neurotherapeutics16, 611–634.
14.
RaiSN, TiwariN, SinghP, MishraD, SinghAK, HooshmandiE, VamanuE, SinghMP (2021) Therapeutic potential of vital transcription factors in Alzheimer’s and Parkinson’s disease with particular emphasis on transcription factor EB mediated autophagy. Front Neurosci15, 777347.
15.
MazharM, DinAU, AliH, YangG, RenW, WangL, FanX, YangS (2021) Implication of ferroptosis in aging. Cell Death Discov7, 149.
16.
RaiSN, SinghC, SinghA, SinghMP, SinghBK (2020) Mitochondrial dysfunction: A potential therapeutic target to treat Alzheimer’s disease. Mol Neurobiol57, 3075–3088.
17.
ZhaoM, DaiY, LiP, WangJ, MaT, XuS (2021) Inhibition of NLRP3 inflammasome activation and pyroptosis with the ethyl acetate fraction of Bungeanum ameliorated cognitive dysfunction in aged mice. Food Funct12, 10443–10458.
18.
MarinelliS, BasilicoB, MarroneMC, RagozzinoD (2019) Microglia-neuron crosstalk: Signaling mechanism and control of synaptic transmission. Semin Cell Dev Biol94, 138–151.
SongX, CuiZ, HeJ, YangT, SunX (2021)
κ-opioid receptor agonist, U50488H, inhibits pyroptosis through NLRP3 via the Ca(2+)/CaMKII/CREB signaling pathway and improves synaptic plasticity in APP/PS1 mice. Mol Med Rep24, 529.
21.
SinghAK, RaiSN, MauryaA, MishraG, AwasthiR, ShakyaA, ChellappanDK, DuaK, VamanuE, ChaudharySK, SinghMP (2021) Therapeutic potential of phytoconstituents in management of Alzheimer’s disease. Evid Based Complement Alternat Med2021, 5578574.
22.
WangX, DavisRL (2021) Early mitochondrial fragmentation and dysfunction in a drosophila model for Alzheimer’s disease. Mol Neurobiol58, 143–155.
23.
ZottB, SimonMM, HongW, UngerF, Chen-EngererHJ, FroschMP, SakmannB, WalshDM, KonnerthA (2019) A vicious cycle of β amyloid-dependent neuronal hyperactivation. Science365, 559–565.
24.
OddoS, CaccamoA, ShepherdJD, MurphyMP, GoldeTE, KayedR, MetherateR, MattsonMP, AkbariY, LaFerlaFM (2003) Triple-transgenic model of Alzheimer’s disease with plaques and tangles: Intracellular Abeta and synaptic dysfunction. Neuron39, 409–421.
25.
TakashimaA (2008) Hyperphosphorylated tau is a cause of neuronal dysfunction in tauopathy. J Alzheimers Dis14, 371–375.
26.
TaiHC, Serrano-PozoA, HashimotoT, FroschMP, Spires-JonesTL, HymanBT (2012) The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. Am J Pathol181, 1426–1435.
27.
StecB, SusekW (2018) Theory and measurement of signal-to-noise ratio in continuous-wave noise radar. Sensors (Basel)18, 1445.
28.
AloniE, Oni-BitonE, TsooryM, MoallemDH, SegalM (2019) Synaptopodin deficiency ameliorates symptoms in the 3xTg mouse model of Alzheimer’s disease. J Neurosci39, 3983–3992.
29.
CuiZQ, HuXY, YangT, GuanJW, GuY, LiHY, ZhangHY, XiaoQH, SunXH (2023) TMEM16F may be a new therapeutic target for Alzheimer’s disease. Neural Regen Res18, 643–651.
30.
PaulCM, MagdaG, AbelS (2009) Spatial memory: Theoretical basis and comparative review on experimental methods in rodents. Behav Brain Res203, 151–164.
BolgerAM, LohseM, UsadelB (2014) Trimmomatic: A flexible trimmer for Illumina sequence data. Bioinformatics30, 2114–2120.
33.
KimD, LangmeadB, SalzbergSL (2015) HISAT: A fast spliced aligner with low memory requirements. Nat Methods12, 357–360.
34.
RobertsA, TrapnellC, DonagheyJ, RinnJL, PachterL (2011) Improving RNA-Seq expression estimates by correcting for fragment bias. Genome Biol12, R22.
35.
TrapnellC, WilliamsBA, PerteaG, MortazaviA, KwanG, van BarenMJ, SalzbergSL, WoldBJ, PachterL (2010) Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol28, 511–515.
36.
AndersS, PylPT, HuberW (2015) HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics31, 166–169.
37.
AndersS, HuberW (2013) Differential expression of RNA-Seq data at the gene level - the DESeq package. EMBL.
38.
KongL, ZhangY, YeZQ, LiuXQ, ZhaoSQ, WeiL, GaoG (2007) CPC: Assess the protein-coding potential of transcripts using sequence features and support vector machine. Nucleic Acids Res35, W345–349.
39.
LiA, ZhangJ, ZhouZ (2014) PLEK: A tool for predicting long non-coding RNAs and messenger RNAs based on an improved k-mer scheme. BMC Bioinformatics15, 311.
40.
SunL, LuoH, BuD, ZhaoG, YuK, ZhangC, LiuY, ChenR, ZhaoY (2013) Utilizing sequence intrinsic composition to classify protein-coding and long non-coding transcripts. Nucleic Acids Res41, e166.
41.
MistryJ, ChuguranskyS, WilliamsL, QureshiM, SalazarGA, SonnhammerELL, TosattoSCE, PaladinL, RajS, RichardsonLJ, FinnRD, BatemanA (2021) Pfam: The protein families database in 2021. Nucleic Acids Res49, D412–d419.
42.
LiXN, WangZJ, YeCX, ZhaoBC, LiZL, YangY (2018) RNA sequencingreveals the expression profiles of circRNA and indicates thatcircDDX17 acts as a tumor suppressor in colorectal cancer. JExp Clin Cancer Res37, 325.
LuoL, ZhangS, GuoN, LiH, HeS (2023) ACSF2-mediated ferroptosis is involved in ulcerative colitis. Life Sci313, 121272.
45.
YangL, ZhangYH, HuangF, LiZ, HuangT, CaiYD (2022) Identification of protein-protein interaction associated functions based on gene ontology and KEGG pathway. Front Genet13, 1011659.
46.
ZhangJ, ZhangJ, ZhaoW, LiQ, ChengW (2022) Low expression of NR1H3 correlates with macrophage infiltration and indicates worse survival in breast cancer. Front Genet13, 1067826.
LiY, MaoM, ZhuL, SunQ, TongJ, ZhouZ (2022) IL-17A drives cognitive aging probably via inducing neuroinflammation and theta oscillation disruption in the hippocampus. Int Immunopharmacol108, 108898.
52.
PrimianiCT, RyanVH, RaoJS, CamMC, AhnK, ModiHR, RapoportSI (2014) Coordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging. PLoS One9, e110972.
53.
NiraulaA, SheridanJF, GodboutJP (2017) Microglia priming with aging and stress. Neuropsychopharmacology42, 318–333.
54.
QiD, WongNML, ShaoR, ManISC, WongCHY, YuenLP, ChanCCH, LeeTMC (2021) Qigong exercise enhances cognitive functions in the elderly via an interleukin-6-hippocampus pathway: A randomized active-controlled trial. Brain Behav Immun95, 381–390.
55.
JuT, SunL, FanY, WangT, LiuY, LiuD, LiuT, ZhaoC, WangW, ChiL (2021) Decreased netrin-1 in mild cognitive impairment and Alzheimer’s disease patients. Front Aging Neurosci13, 762649.
56.
FonsecaMI, ZhouJ, BottoM, TennerAJ (2004) Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer’s disease. J Neurosci24, 6457–6465.
57.
WilkinsHM, SwerdlowRH (2017) Amyloid precursor protein processing and bioenergetics. Brain Res Bull133, 71–79.
58.
HartlD, RoheM, MaoL, StaufenbielM, ZabelC, KloseJ (2008) Impairment of adolescent hippocampal plasticity in a mouse model for Alzheimer’s disease precedes disease phenotype. PLoS One3, e2759.
59.
BillingsLM, OddoS, GreenKN, McGaughJL, LaFerlaFM (2005) Intraneuronal Abeta causes the onset of early Alzheimer’s disease-related cognitive deficits in transgenic mice. Neuron45, 675–688.
60.
ZhaoY, WuX, LiX, JiangLL, GuiX, LiuY, SunY, ZhuB, Piña-CrespoJC, ZhangM, ZhangN, ChenX, BuG, AnZ, HuangTY, XuH (2018) TREM2 is a receptor for β-amyloid that mediates microglial function. Neuron97, 1023–1031.e1027.
61.
ElKhoury J, LusterAD (2008) Mechanisms of microglia accumulation in Alzheimer’s disease: Therapeutic implications. Trends Pharmacol Sci29, 626–632.
62.
TanziRE, BertramL (2005) Twenty years of the Alzheimer’s disease amyloid hypothesis: A genetic perspective. Cell120, 545–555.
63.
RajmohanR, ReddyPH (2017) Amyloid-beta and phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer’s disease neurons. J Alzheimers Dis57, 975–999.
64.
OkuzonoY, SakumaH, MiyakawaS, IfukuM, LeeJ, DasD, BanerjeeA, ZhaoY, YamamotoK, AndoT, SatoS (2021) Reduced TREM2 activation in microglia of patients with Alzheimer’s disease. FEBS Open Bio11, 3063–3080.
65.
GriciucA, PatelS, FedericoAN, ChoiSH, InnesBJ, OramMK, CereghettiG, McGintyD, AnselmoA, SadreyevRI, HickmanSE, El KhouryJ, ColonnaM, TanziRE (2019) TREM2 acts downstream of CD33 in modulating microglial pathology in Alzheimer’s disease. Neuron103, 820–835.e827.
